 | • レポートコード：D0GIR-01581 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、胆管炎の世界市場を広く調査・分析し、今後の市場展望をまとめております。胆管炎の種類別市場規模（急性胆管炎、原発性硬化性胆管炎、二次性硬化性胆管炎、再発性化膿性胆管炎）、用途別市場規模（臨床実習、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Taiho Pharmaceutical、Gilead Sciences、Mayo Clinic、Bayer、Zambon、RiemserArzneimittel ・地域別グローバル市場分析 2015年-2020年 ・胆管炎の北米市場（アメリカ、カナダ、メキシコ） ・胆管炎のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・胆管炎のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・胆管炎の南米市場（ブラジル、アルゼンチン） ・胆管炎の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：急性胆管炎、原発性硬化性胆管炎、二次性硬化性胆管炎、再発性化膿性胆管炎 ・用途別分析：臨床実習、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Cholangitis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Cholangitis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cholangitis market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cholangitis market has been segmented into:
Acute Cholangitis
Primary Sclerosing Cholangitis
Secondary Sclerosing Cholangitis
Recurrent Pyogenic Cholangitis
By Application, Cholangitis has been segmented into:
Clinical Practise
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cholangitis market presented in the report. This section sheds light on the sales growth of different regional and country-level Cholangitis markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cholangitis market.
The report offers in-depth assessment of the growth and other aspects of the Cholangitis market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cholangitis Market Share Analysis
Cholangitis competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cholangitis sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cholangitis sales, revenue and market share for each player covered in this report.
The major players covered in Cholangitis are:
Taiho Pharmaceutical
Gilead Sciences
Mayo Clinic
Bayer
Zambon
RiemserArzneimittel
Table of Contents
1 Cholangitis Market Overview
1.1 Product Overview and Scope of Cholangitis
1.2 Classification of Cholangitis by Type
1.2.1 Global Cholangitis Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cholangitis Revenue Market Share by Type in 2019
1.2.3 Acute Cholangitis
1.2.4 Primary Sclerosing Cholangitis
1.2.5 Secondary Sclerosing Cholangitis
1.2.6 Recurrent Pyogenic Cholangitis
1.3 Global Cholangitis Market by Application
1.3.1 Overview: Global Cholangitis Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinical Practise
1.3.3 Others
1.4 Global Cholangitis Market by Regions
1.4.1 Global Cholangitis Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cholangitis (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cholangitis Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cholangitis Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cholangitis Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cholangitis Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cholangitis Status and Prospect (2015-2025)
2 Company Profiles
2.1 Taiho Pharmaceutical
2.1.1 Taiho Pharmaceutical Details
2.1.2 Taiho Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Taiho Pharmaceutical SWOT Analysis
2.1.4 Taiho Pharmaceutical Product and Services
2.1.5 Taiho Pharmaceutical Cholangitis Revenue, Gross Margin and Market Share (2018-2019)
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Gilead Sciences SWOT Analysis
2.2.4 Gilead Sciences Product and Services
2.2.5 Gilead Sciences Cholangitis Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mayo Clinic
2.3.1 Mayo Clinic Details
2.3.2 Mayo Clinic Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Mayo Clinic SWOT Analysis
2.3.4 Mayo Clinic Product and Services
2.3.5 Mayo Clinic Cholangitis Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer SWOT Analysis
2.4.4 Bayer Product and Services
2.4.5 Bayer Cholangitis Revenue, Gross Margin and Market Share (2018-2019)
2.5 Zambon
2.5.1 Zambon Details
2.5.2 Zambon Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Zambon SWOT Analysis
2.5.4 Zambon Product and Services
2.5.5 Zambon Cholangitis Revenue, Gross Margin and Market Share (2018-2019)
2.6 RiemserArzneimittel
2.6.1 RiemserArzneimittel Details
2.6.2 RiemserArzneimittel Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 RiemserArzneimittel SWOT Analysis
2.6.4 RiemserArzneimittel Product and Services
2.6.5 RiemserArzneimittel Cholangitis Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cholangitis Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cholangitis Players Market Share
3.2.2 Top 10 Cholangitis Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cholangitis Revenue and Market Share by Regions
4.2 North America Cholangitis Revenue and Growth Rate (2015-2020)
4.3 Europe Cholangitis Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cholangitis Revenue and Growth Rate (2015-2020)
4.5 South America Cholangitis Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cholangitis Revenue and Growth Rate (2015-2020)
5 North America Cholangitis Revenue by Countries
5.1 North America Cholangitis Revenue by Countries (2015-2020)
5.2 USA Cholangitis Revenue and Growth Rate (2015-2020)
5.3 Canada Cholangitis Revenue and Growth Rate (2015-2020)
5.4 Mexico Cholangitis Revenue and Growth Rate (2015-2020)
6 Europe Cholangitis Revenue by Countries
6.1 Europe Cholangitis Revenue by Countries (2015-2020)
6.2 Germany Cholangitis Revenue and Growth Rate (2015-2020)
6.3 UK Cholangitis Revenue and Growth Rate (2015-2020)
6.4 France Cholangitis Revenue and Growth Rate (2015-2020)
6.5 Russia Cholangitis Revenue and Growth Rate (2015-2020)
6.6 Italy Cholangitis Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cholangitis Revenue by Countries
7.1 Asia-Pacific Cholangitis Revenue by Countries (2015-2020)
7.2 China Cholangitis Revenue and Growth Rate (2015-2020)
7.3 Japan Cholangitis Revenue and Growth Rate (2015-2020)
7.4 Korea Cholangitis Revenue and Growth Rate (2015-2020)
7.5 India Cholangitis Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cholangitis Revenue and Growth Rate (2015-2020)
8 South America Cholangitis Revenue by Countries
8.1 South America Cholangitis Revenue by Countries (2015-2020)
8.2 Brazil Cholangitis Revenue and Growth Rate (2015-2020)
8.3 Argentina Cholangitis Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cholangitis by Countries
9.1 Middle East & Africa Cholangitis Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cholangitis Revenue and Growth Rate (2015-2020)
9.3 UAE Cholangitis Revenue and Growth Rate (2015-2020)
9.4 Egypt Cholangitis Revenue and Growth Rate (2015-2020)
9.5 South Africa Cholangitis Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cholangitis Revenue and Market Share by Type (2015-2020)
10.2 Global Cholangitis Market Forecast by Type (2019-2024)
10.3 Acute Cholangitis Revenue Growth Rate (2015-2025)
10.4 Primary Sclerosing Cholangitis Revenue Growth Rate (2015-2025)
10.5 Secondary Sclerosing Cholangitis Revenue Growth Rate (2015-2025)
10.6 Recurrent Pyogenic Cholangitis Revenue Growth Rate (2015-2025)
11 Global Cholangitis Market Segment by Application
11.1 Global Cholangitis Revenue Market Share by Application (2015-2020)
11.2 Cholangitis Market Forecast by Application (2019-2024)
11.3 Clinical Practise Revenue Growth (2015-2020)
11.4 Others Revenue Growth (2015-2020)
12 Global Cholangitis Market Size Forecast (2021-2025)
12.1 Global Cholangitis Market Size Forecast (2021-2025)
12.2 Global Cholangitis Market Forecast by Regions (2021-2025)
12.3 North America Cholangitis Revenue Market Forecast (2021-2025)
12.4 Europe Cholangitis Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cholangitis Revenue Market Forecast (2021-2025)
12.6 South America Cholangitis Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cholangitis Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cholangitis Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cholangitis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cholangitis Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cholangitis Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Taiho Pharmaceutical Corporate Information, Location and Competitors
Table 6. Taiho Pharmaceutical Cholangitis Major Business
Table 7. Taiho Pharmaceutical Cholangitis Total Revenue (USD Million) (2017-2018)
Table 8. Taiho Pharmaceutical SWOT Analysis
Table 9. Taiho Pharmaceutical Cholangitis Product and Solutions
Table 10. Taiho Pharmaceutical Cholangitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Gilead Sciences Corporate Information, Location and Competitors
Table 12. Gilead Sciences Cholangitis Major Business
Table 13. Gilead Sciences Cholangitis Total Revenue (USD Million) (2018-2019)
Table 14. Gilead Sciences SWOT Analysis
Table 15. Gilead Sciences Cholangitis Product and Solutions
Table 16. Gilead Sciences Cholangitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Mayo Clinic Corporate Information, Location and Competitors
Table 18. Mayo Clinic Cholangitis Major Business
Table 19. Mayo Clinic Cholangitis Total Revenue (USD Million) (2017-2018)
Table 20. Mayo Clinic SWOT Analysis
Table 21. Mayo Clinic Cholangitis Product and Solutions
Table 22. Mayo Clinic Cholangitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bayer Corporate Information, Location and Competitors
Table 24. Bayer Cholangitis Major Business
Table 25. Bayer Cholangitis Total Revenue (USD Million) (2017-2018)
Table 26. Bayer SWOT Analysis
Table 27. Bayer Cholangitis Product and Solutions
Table 28. Bayer Cholangitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Zambon Corporate Information, Location and Competitors
Table 30. Zambon Cholangitis Major Business
Table 31. Zambon Cholangitis Total Revenue (USD Million) (2017-2018)
Table 32. Zambon SWOT Analysis
Table 33. Zambon Cholangitis Product and Solutions
Table 34. Zambon Cholangitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. RiemserArzneimittel Corporate Information, Location and Competitors
Table 36. RiemserArzneimittel Cholangitis Major Business
Table 37. RiemserArzneimittel Cholangitis Total Revenue (USD Million) (2017-2018)
Table 38. RiemserArzneimittel SWOT Analysis
Table 39. RiemserArzneimittel Cholangitis Product and Solutions
Table 40. RiemserArzneimittel Cholangitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Cholangitis Revenue (Million USD) by Players (2015-2020)
Table 42. Global Cholangitis Revenue Share by Players (2015-2020)
Table 43. Global Cholangitis Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Cholangitis Revenue Market Share by Regions (2015-2020)
Table 45. North America Cholangitis Revenue by Countries (2015-2020)
Table 46. North America Cholangitis Revenue Market Share by Countries (2015-2020)
Table 47. Europe Cholangitis Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Cholangitis Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Cholangitis Revenue by Countries (2015-2020)
Table 50. South America Cholangitis Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Cholangitis Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Cholangitis Revenue Market Share by Countries (2015-2020)
Table 53. Global Cholangitis Revenue (Million USD) by Type (2015-2020)
Table 54. Global Cholangitis Revenue Share by Type (2015-2020)
Table 55. Global Cholangitis Revenue Forecast by Type (2021-2025)
Table 56. Global Cholangitis Revenue by Application (2015-2020)
Table 57. Global Cholangitis Revenue Share by Application (2015-2020)
Table 58. Global Cholangitis Revenue Forecast by Application (2021-2025)
Table 59. Global Cholangitis Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cholangitis Picture
Figure 2. Global Cholangitis Revenue Market Share by Type in 2019
Figure 3. Acute Cholangitis Picture
Figure 4. Primary Sclerosing Cholangitis Picture
Figure 5. Secondary Sclerosing Cholangitis Picture
Figure 6. Recurrent Pyogenic Cholangitis Picture
Figure 7. Cholangitis Revenue Market Share by Application in 2019
Figure 8. Clinical Practise Picture
Figure 9. Others Picture
Figure 10. Global Cholangitis Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Cholangitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Cholangitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Cholangitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Cholangitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Cholangitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Cholangitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Cholangitis Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Cholangitis Revenue Market Share in 2019
Figure 19. Global Top 10 Players Cholangitis Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Cholangitis Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Cholangitis Revenue Market Share by Regions (2015-2020)
Figure 23. Global Cholangitis Revenue Market Share by Regions in 2018
Figure 24. North America Cholangitis Revenue and Growth Rate (2015-2020)
Figure 25. Europe Cholangitis Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Cholangitis Revenue and Growth Rate (2015-2020)
Figure 27. South America Cholangitis Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Cholangitis Revenue and Growth Rate (2015-2020)
Figure 29. North America Cholangitis Revenue Market Share by Countries (2015-2020)
Figure 30. North America Cholangitis Revenue Market Share by Countries in 2019
Figure 31. USA Cholangitis Revenue and Growth Rate (2015-2020)
Figure 32. Canada Cholangitis Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Cholangitis Revenue and Growth Rate (2015-2020)
Figure 34. Europe Cholangitis Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Cholangitis Revenue Market Share by Countries in 2019
Figure 36. Germany Cholangitis Revenue and Growth Rate (2015-2020)
Figure 37. UK Cholangitis Revenue and Growth Rate (2015-2020)
Figure 38. France Cholangitis Revenue and Growth Rate (2015-2020)
Figure 39. Russia Cholangitis Revenue and Growth Rate (2015-2020)
Figure 40. Italy Cholangitis Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Cholangitis Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Cholangitis Revenue Market Share by Countries in 2019
Figure 43. China Cholangitis Revenue and Growth Rate (2015-2020)
Figure 44. Japan Cholangitis Revenue and Growth Rate (2015-2020)
Figure 45. Korea Cholangitis Revenue and Growth Rate (2015-2020)
Figure 46. India Cholangitis Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Cholangitis Revenue and Growth Rate (2015-2020)
Figure 48. South America Cholangitis Revenue Market Share by Countries (2015-2020)
Figure 49. South America Cholangitis Revenue Market Share by Countries in 2019
Figure 50. Brazil Cholangitis Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Cholangitis Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Cholangitis Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Cholangitis Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Cholangitis Revenue and Growth Rate (2015-2020)
Figure 55. UAE Cholangitis Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Cholangitis Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Cholangitis Revenue and Growth Rate (2015-2020)
Figure 58. Global Cholangitis Revenue Share by Type (2015-2020)
Figure 59. Global Cholangitis Revenue Share by Type in 2019
Figure 60. Global Cholangitis Market Share Forecast by Type (2021-2025)
Figure 61. Global Acute Cholangitis Revenue Growth Rate (2015-2020)
Figure 62. Global Primary Sclerosing Cholangitis Revenue Growth Rate (2015-2020)
Figure 63. Global Secondary Sclerosing Cholangitis Revenue Growth Rate (2015-2020)
Figure 64. Global Recurrent Pyogenic Cholangitis Revenue Growth Rate (2015-2020)
Figure 65. Global Cholangitis Revenue Share by Application (2015-2020)
Figure 66. Global Cholangitis Revenue Share by Application in 2019
Figure 67. Global Cholangitis Market Share Forecast by Application (2021-2025)
Figure 68. Global Clinical Practise Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Cholangitis Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Cholangitis Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Cholangitis Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Cholangitis Revenue Market Forecast (2021-2025)
Figure 74. Europe Cholangitis Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Cholangitis Revenue Market Forecast (2021-2025)
Figure 76. South America Cholangitis Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Cholangitis Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
再発多形神経膠芽腫（GBM）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Recurrent Glioblastoma Multiforme (GBM) Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.…- 急性肝性ポルフィリン症治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Acute Hepatic Porphyria Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 急性虚血性脳卒中治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Acute Ischemic Stroke Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.0% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Acute Isc…
- 急性冠症候群（ACS）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Acute Coronary Syndrome (ACS) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.6% in the forecast period of 2020 to 2025 and will expected to reach USD 9240.7 million by 2025, from USD 8032.3 million in 2019. The Acute …
- 急性肺障害の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Acute Lung Injury market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.7% in the forecast period of 2020 to 2025 and will expected to reach USD 637.6 million by 2025, from USD 531.6 million in 2019. The Acute Lung Injury ma…